Skip to content

The effect of intravenous Ketamine for vesical tenesmus after transuretheral surgery

The effect of intravenous Ketamine for vesical tenesmus after transuretheral surgery - The effect of Ketamine for vesical tenesmus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024628
Enrollment
96
Registered
2016-10-31
Start date
2016-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transuretheral surgery as follows. TUR-Bt, TUL, TUR-P, HoLEP

Interventions

Allocate the patients in each operation to Ketamine group and Control group. In the Ketamine group, Ketamine 0.25 mg/kg is administrated intravenously before the surgery. Allocate the patients in each

Sponsors

Tokyo Metropolitan Police Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Adult male patients whose age are between 20 and 80 years old. 2) Patients undergoing transuretheral surgery.

Exclusion criteria

Exclusion criteria: 1) Patients suffering cerebrovascular disease,hypertension; systolic blood pressure over 160mmHg/ diastolic blood pressure over 100mmHg,hyper high intracranial pressure,and severe heart failure. 2) Past medical history of convulsion. 3) BMI over 35 4) Other patients judged as inadequate by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Assessment of post-operative viscical tenesmus by using tenesmus score.

Countries

Japan

Contacts

Public ContactTomoko Mae

Tokyo Metropolitan Police Hospital Department of Anesthesiology

chikomae@sa2.so-net.ne.jp03-5343-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026